| |
| |
|
| Insider
Information: |
Conroy Kevin T |
| Relationship: |
|
| City: |
Madison |
| State: |
WI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,204,819 |
|
|
Indirect Shares
|
238,579 |
|
|
| Direct
Value |
$57,924,779 |
|
|
|
Indirect Value
|
$11,890,777 |
|
|
| Total
Shares |
1,443,398 |
|
|
| Total
Value |
$69,815,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exact Sciences Corp |
EXAS |
|
2024-05-01 |
1,156,191 |
2024-05-01 |
238,579 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Director |
2022-08-12 |
0 |
2018-07-02 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2023-03-06 |
22,968 |
2021-02-14 |
0 |
Premium* |
|
|
Cm Life Sciences Ii Inc. |
SLGC |
Director |
2021-09-01 |
25,000 |
2021-09-01 |
0 |
Premium* |
|
|
Align Technology Inc |
ALGN |
|
2024-05-22 |
660 |
2024-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
196 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2020-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
35,750 |
789,954 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2020-12-31 |
4 |
A |
$10.86 |
$11,121 |
D/D |
1,024 |
9,559 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-01-04 |
4 |
AS |
$128.74 |
$4,095,734 |
D/D |
(31,814) |
825,704 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-01 |
4 |
AS |
$138.07 |
$4,189,596 |
D/D |
(30,344) |
759,610 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-05 |
4 |
OE |
$5.70 |
$99,995 |
D/D |
17,543 |
777,153 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,504 |
1,504 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,132 |
808,285 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-17 |
4 |
AS |
$142.66 |
$2,257,595 |
D/D |
(15,825) |
792,460 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,325 |
826,785 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-24 |
4 |
AS |
$136.30 |
$2,238,046 |
D/D |
(16,420) |
810,365 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,312 |
819,677 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-03-01 |
4 |
AS |
$136.79 |
$4,283,387 |
D/D |
(31,293) |
788,384 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,575 |
808,959 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-03-02 |
4 |
AS |
$138.42 |
$1,355,962 |
D/D |
(9,796) |
799,163 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-03-31 |
4 |
A |
$8.71 |
$15,007 |
D/D |
1,723 |
11,282 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-04-30 |
4 |
A |
$64.74 |
$21,235 |
D/D |
328 |
776,736 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-05-03 |
4 |
AS |
$131.09 |
$2,522,172 |
D/D |
(19,240) |
757,496 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$111.00 |
$1,374,624 |
D/D |
(12,384) |
745,112 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
8,060 |
19,342 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$8.31 |
$15,000 |
D/D |
1,805 |
21,147 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-07-01 |
4 |
AS |
$123.43 |
$960,779 |
D/D |
(7,784) |
737,328 |
0 |
% |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-08-02 |
4 |
AS |
$107.50 |
$2,146,775 |
D/D |
(19,970) |
717,358 |
0 |
% |
|
| SLGC |
Cm Life Sciences Ii Inc. |
Director |
– • – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| EXAS |
Exact Sciences Corp |
President and CEO |
• • – |
2021-09-01 |
4 |
AS |
$104.42 |
$1,981,683 |
D/D |
(18,978) |
698,380 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Director |
– • – |
2021-09-30 |
4 |
A |
$5.12 |
$15,002 |
D/D |
2,930 |
24,077 |
0 |
- |
|
196 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
